chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client received 7.5mcg of vaccine from purple cap vaccine instead of prescribed dose of 10 mcg from orange cap. Dr. was notified. Explained situation, including how vaccine was diluted to come to final dose. Dr. is confident client will have a good immune response, advised no need to re-vaccinate. Asked that parents be encouraged to seek out a booster for her when/if they become available. Clients Mom was informed of incident and Dr.'s advice.
feel like it lowered my immune system; This case was reported by a consumer via call center representative and described the occurrence of immune system disorder in a 66-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced immune system disorder. On an unknown date, the outcome of the immune system disorder was unknown.   It was unknown if the reporter considered the immune system disorder to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient took the last injection and felt like it lowered my immune system and was just wondering how long the side effects last. The patient asked how long does the side effects last with the shingles shot.
Immediately after vaccines given pt c/o not feeling well and pale, non-responsive, placed on floor O2 via mask 10L administered and pulse ox 99, glucose 82, BP 130/80, P 92. Pt responsive. Epipen 0.3mg IM LT, Benadryl 50mg IM RT, BP 116/70. Ambulance transported and pt to respond for evaluation.
This spontaneous report was received from a physician and referred to 47 patients of unknown age and gender. On unknown dates, the patients were vaccinated with unspecified doses of VARIVAX (dose, route of administration, lot# and expiration date were not reported). The VARIVAX was reconstituted with sterile diluent (MERCK). The physician reported about the patients' "varicella titer" tests. The results were stating that the varicella titer was equivalent. The physician stated that he was not sure, what the term "equivalent" was referring to. The outcome of varicella titer equivalent was not reported. The causality assessment was not reported. Additional information has been requested. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1708USA008911.
On 1/10/06 pt received influenza and pneumococcal vaccine in the left deltoid area. Pt returned on 1/13/06 reporting increased swelling and redness in this area. DR. assessed pt placed on Augmentin 875 mg bid x8 days.
4-6PM; irritability, high pitched crying; 6-7PM unilateral leg clonus (10-12 beats), followed by unilateral arm clonus & jaw twitching; max rectal temp 37.8; 7PM called MD on call who relayed episode to MD next day;
Patient came in for well child check and was fine. Immunizations given were Pediarix, HIB and Prevnar. Afterward, patient developed a fever and came to the ED the next day. He was admitted for high fever and viral meningitis. DC Summary for DOS 6/21-6/25/06 DC DX: Viral Meningitis  temperatures and cold sweats 36 hours prior to ED visit. Temp on admission 39.6.
I am in perfect health,  I have no medical issue as of my recent blood work done on 07/05/2021.  Two days after taking the Pfizer covid 19 shot i went to the mall walking around. I was about to sit down and my leg starts locking up. it went from locking up to serious cramping through my body around dropping me to the floor. it lasts for about 30 seconds.  a week later it happened again since then it keeping happen.  After I took the second shot the frequency became more ofter.  went to the doc two times and they can't explain what is happening to me.  It can be super dangerous and I feel that is some sort of a side effect for the shots.   it is still ongoing.
VARIVAX was given instead of ZOSTAVAX. 10/29/12 Vaccinated with ZOSTAVAX on this date.
gallstones; Blood tests had significant problems in liver, kidney and pancreas; Without any food and sleeping / He could not fall asleep due to the illness; Without any food; Vomiting; Nausea; Gallbladder issue; consistently had hiccups; This spontaneous case was reported by a consumer and describes the occurrence of GALLBLADDER DISORDER (Gallbladder issue), HICCUPS (consistently had hiccups), CHOLELITHIASIS (gallstones), BLOOD TEST ABNORMAL (Blood tests had significant problems in liver, kidney and pancreas) and INSOMNIA (Without any food and sleeping / He could not fall asleep due to the illness) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Gallstones.   On 12-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, the patient experienced GALLBLADDER DISORDER (Gallbladder issue), HICCUPS (consistently had hiccups), INSOMNIA (Without any food and sleeping / He could not fall asleep due to the illness), FEEDING DISORDER (Without any food), VOMITING (Vomiting) and NAUSEA (Nausea). On 25-May-2021, the patient experienced CHOLELITHIASIS (gallstones) and BLOOD TEST ABNORMAL (Blood tests had significant problems in liver, kidney and pancreas). The patient was treated with ONDANSETRON on 13-May-2021 at a dose of 1 dosage form four times per day. At the time of the report, GALLBLADDER DISORDER (Gallbladder issue), INSOMNIA (Without any food and sleeping / He could not fall asleep due to the illness), FEEDING DISORDER (Without any food) and NAUSEA (Nausea) outcome was unknown and HICCUPS (consistently had hiccups), CHOLELITHIASIS (gallstones), BLOOD TEST ABNORMAL (Blood tests had significant problems in liver, kidney and pancreas) and VOMITING (Vomiting) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-May-2021, Blood test: abnormal Liver, kidney and pancreas.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Additional information received on 14-JUN-2021 contains significant information-Patient demographics and events were updated.
Delayed onset 2.28.21 of redness, swelling, induration starting from bruised vaccine site from 2.17.21, extending distally to involve the entire upper extremity.  Further evaluation beginning now.
Pt received 1st Moderna covid vaccine Wednesday  1/20/21. Pt's daughter reports pt is having hallucinations and hip pain starting 1/23/21. Pt has not been seen by PCP in ~2 years for baseline comparison. Daughter reports pt is doing somewhat better as of 1/25/21. Working to get pt seen for follow-up by provider.
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Mild, Additional Details: Patient had a lump beneath where the shot was given and slightly below the arm pit. Also noted some pain radiating up into the neck and shoulders approximately 2-3 hours afterwards.
Patient received a monovalent dose - lot 044c22a 0.5ml - instead of a bivalent dose as a 4th dose; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient received a monovalent dose - lot 044c22a 0.5ml - instead of a bivalent dose as a 4th dose) and NO ADVERSE EVENT (No adverse event) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044c22a) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On an unknown date, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form, second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Patient received a monovalent dose - lot 044c22a 0.5ml - instead of a bivalent dose as a 4th dose) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient received a monovalent dose - lot 044c22a 0.5ml - instead of a bivalent dose as a 4th dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient received a monovalent dose - lot 044c22a 0.5ml - instead of a bivalent dose as a 4th dose).    No concomitant medications were reported. No treatment information was provided.
This case was reported by a pharmacist via call center representative and described the occurrence of hives in a 73-year-old female patient who received SHINGRIX (batch number 957J3, expiry date 15th November 2020) for prophylaxis. On 21st August 2018, the patient received the 1st dose of SHINGRIX(intramuscular) .5 ml. In August 2018, less than a week after receiving SHINGRIX, the patient experienced hives and pruritus. In August 2018, the outcome of the hives and pruritus were recovered/resolved. It was unknown if the reporter considered the hives and pruritus to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX in right arm. The pharmacist reported that the patient broke out with hives on her right back shoulder along with itching. The hives and itching was four by four in inches. This lasted for a couple of days. No further details were provided.
A report was received from a healthcare professional on 10/14/2003 concerning an 8 month old male vaccinee who received Fluvirin on 10/14/2003.  On 10/14/2003 the vaccinee inadvertently received 0.25ml Fluvirin intramuscularly.  No adverse effects were reported at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 1, 24 November 2003  Follow-up information received from a healthcare professional indicated that the vaccinee did not experience any adverse reaction.
Upon day #18, MMR, Varicella vaccine, 2 hours after vaccine given a strange rash on stomach and high fever (that was 12 months of age) has broke out every month with same rash and symptoms.  Had Pneumonia 2 months after vaccine along with a "black-out" seizure.  Rash kepts getting worse, erythema multiforme.  Medical charts have been requested to be forwarded to clinic.
Very, very Severe pain in right leg upper leg near hip area. - never had this pain before. Nothing has relieved the pain for him. He went to Primary care and urgent.  Still having very severe pain in the same leg. waiting to see pain management doctor.
Pharmacist was informed by patient that she has a history of fainting with any injections. Pharmacist had a technician on stand-by to help assist with patient. Patient was talking and fine during the injection. However, soon after her injection was given (around 9:50 am), patient fainted and was unresponsive for about one minute. Since the pharmacist and technician were aware of her history, they were able to prop her up right and stop her from falling off the chair. A cold compress was also placed around her neck. She became responsive again and stated she was seeing "purple dots" in her vision and feeling nauseous. She also stated she had not eaten all day. Water was given to her. A few minutes later, she fainted again and regained consciousness a few seconds after. She then asked to lay down on ground and that she was both cold and hot (sweating) and was experiencing a "tingling" feeling in both her hands. Placed a sweater over her to keep her warm. She asked for us to massage her hands to relieve the "tingling" feeling. She laid on the ground for around 20-30 minutes covered with a sweater and with us massaging her hands. She was also given a Sprite to sip on. She eventually was able to stand up and walk after about 40 minutes post vaccination.
suffered sharp, tingling and burning pain on her left shoulder and was diagnosed with herpes zoster, post herpetic polyneuropathy and vertigo; suffered sharp, tingling and burning pain on her left shoulder and was diagnosed with herpes zoster, post herpetic polyneuropathy and vertigo; suffered sharp, tingling and burning pain on her left shoulder and was diagnosed with herpes zoster, post herpetic polyneuropathy and vertigo; Information has been received from a lawyer regarding a case in litigation concerning a female patient (pt) of unknown age. The pt's medical history, concurrent conditions and concomitant medications were not provided. On or around 28-DEC-2016, the pt was inoculated with zoster vaccine live(ZOSTAVAX) (dose, route of administration, anatomical location, lot#, expiration date were unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unknown date (reported as "shortly") after receiving zoster vaccine live(ZOSTAVAX), the pt suffered sharp, tingling and burning pain on her left shoulder and was diagnosed with herpes zoster, post herpetic polyneuropathy and vertigo. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the pt's symptoms had resulted in physical limitations, which not present prior to using zoster vaccine live (ZOSTAVAX). The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition.
Shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 63-year-old male patient who received Herpes zoster (Shingrix) (batch number BF4J5, expiry date 5th July 2021) for prophylaxis.   On 29th April 2019, the patient received the 1st dose of Shingrix .5 ml. On an unknown date, 49 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in Left deltoid. The reporter stated that, the patient and his wife received the Shingrix vaccine on 29th April 2019. About 7 weeks after the 1st dose, the patient got the shingles. The reporter consented to follow up.
-Patient had vaccine Feb 15. -Had home care nurse look at arm Feb 16 - Red, warm, arm hurt. -Called Pharmacy Feb 20 to complain arm - Red, warm, painful - area larger.
Joint swelling, after shot along with hive-like lesions throughout leaving hyperpigmented areas. 1st 2 symptoms gone, 3rd improving. 1st shot about 4 years ago. Last about 3 weeks ago.
Fever started 03/16/09 and developed generalized rubelliform rash- continues to today though now defervesced.
Persistent pain in the left arm and shoulder along with reduced mobility and range of motion.  It began the day after receiving the injection and persists to the present day, two and a half months later.  I do not know if there is permanent damage/disability, as I have not been able to see a doctor/surgeon yet. I plan to see one as soon as I am able.
I have had a headache almost continuous since receiving my Flu shot on Friday, September 11, 2020.
Migraine headaches, dizziness, trouble sleeping, feeling sick, tired, muscle joint aches, memory problems, ringing in my ears, depressed, light hurting my eyes, high blood pressure, throwing up.
upset stomach; short of breath; fast heartbeat; lack of sleep; feels weak; headache; Off and on headache; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (upset stomach), DYSPNOEA (short of breath), HEART RATE INCREASED (fast heartbeat), INSOMNIA (lack of sleep) and ASTHENIA (feels weak) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (upset stomach), DYSPNOEA (short of breath), HEART RATE INCREASED (fast heartbeat), INSOMNIA (lack of sleep), ASTHENIA (feels weak), HEADACHE (headache) and HEADACHE (Off and on headache). At the time of the report, ABDOMINAL DISCOMFORT (upset stomach), DYSPNOEA (short of breath), HEART RATE INCREASED (fast heartbeat), INSOMNIA (lack of sleep), ASTHENIA (feels weak), HEADACHE (headache) and HEADACHE (Off and on headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
10-9-07 Left leg Varicella and PCV7 vaccine given 1:00 10-18-07 TC from mother Pt at doctor's office to to temp. and hematoma on left leg. Pt given Amoxicillin.
A non-serious spontaneous report of "gave patient expired FLUMIST" was received from a health professional concerning a 23-year-old male. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 22-Nov-2010. The patient received the expired FLUMIST on 29-Nov-2010. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved. There were no late occurring adverse events. Additional information was received on 04-Mar-2011 and incorporated into the narrative: updated patient's gender, no late occurring adverse events was reported.
Cough; Dry Throat; Sore Throat; Tired; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore Throat), COUGH (Cough), DRY THROAT (Dry Throat) and FATIGUE (Tired) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jul-2021, the patient experienced FATIGUE (Tired). On 27-Jul-2021, the patient experienced OROPHARYNGEAL PAIN (Sore Throat) and DRY THROAT (Dry Throat). On 29-Jul-2021, the patient experienced COUGH (Cough). On 28-Jul-2021, FATIGUE (Tired) had resolved. At the time of the report, OROPHARYNGEAL PAIN (Sore Throat), COUGH (Cough) and DRY THROAT (Dry Throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
The pt experienced a viral illness with a bronchospasm. The pt experienced a vesicular rash on back and left thigh for 2 days. The pt's rash is consistent with Herpes Zoster. Follow-up notes state that the cough is gone. Rash treated with calamine lotion.
Information has been received from a registered nurse concerning a current 8 year old female patient with no pertinent medical history, no drug reactions/allergies, who a few years ago was vaccinated with a first dose of VARIVAX (Merck) (Lot # not reported) IM. The nurse reported that the patient broke out in shingles sometime after her first dose of VARIVAX (Merck) few years ago. There were no Lab diagnosis/studies performed. The patient sought unspecified medical attention. The patient recovered a few years ago. Follow up information has been received from a nurse indicating that this was not her patient and she was not practicing at this time. Additional information is not expected.
Information has been received from a health professional concerning a 4 year old male with no past medial history who on 10/29/1997 was vaccinated with varicella vaccine. On 03/10/2001 the pt experienced atypical chicken pox. It was reported that the pt was seen in the doctor's office. The rash was described as "numerous tiny lesions in various stages-small vesicles-tiny scabs." The pt recovered from his chicken pox after 5 days. No other information was provided. Additional info is not expected.
Both knees became swollen, warm, and she couldn't bear wt on them. Was hospitalized. 11/12/09:  ED Record, Discharge Summary and Hospital records for dates of service 9/27/09 to 9/29/09.  Final Dx:  Allergic reaction to influenza shot. Assessment:  Presented with tense swelling in both knees, increased warmth, dependent edema, unable to walk.  Responded to IV steroids.  Discharged able to weight bear, although still painful.    11/13/09: Laboratory test report with duplicate records of hospital discharge summary and hospital emergency room records for dates of service 9/27/09 to 9/29/09 received. Presented with knee pain.   Labs: Sed Rate 32 and Uric Acid 6.9.  PMH: Osteoarthritis of knees and left shoulder.\rem
At 6:30 AM on 4/10/19 she woke up with significant facial swelling, hives on her face, neck, arms, and chest, and a rash on her face, arms, chest and neck. She was given 1, 25 mg BENADRYL that had no effect on the hives/swelling/rash. She was taken to the ER (no urgent care or her Pediatrician's office were open). She arrived at the ER by 9:15 AM. She was treated by an ER doctor who said that most likely she was having an allergic reaction to a preservative in one of the vaccines. She was prescribed PEPCID and Prednisone for 5 days, and over the counter BENADRYL every 8 hours. 4/10/19 and 4/11/19 the swelling had gone down, but hives and the rashes were still very evident even with rounds of BENADRYL. She complained of joint pain in her knees, ankles, neck, and elbows. The rash became more widespread although the hives would come and go. She did not go to school on these two days. An appointment with an allergy specialist was made for 4/23/19 with the head of the food allergy doctor. On 4/12/19 we followed up with the Pediatrician (recommended by ER doctor) who examined the rashes and witnessed another round of hives after BENADRYL had worn off. She contacted Allergy to get more information and possibly a second opinion on course of action as her symptoms were not improving and the Pediatrician was worried that the steroids wouldn't work (5 days with the same dosage) I was advised to up the BENADRYL to every 4-6 hours and apply hydrocortisone cream to the rashes. Allergy upped the appointment from 4/23/19 to 4/15/19. As of 4/12/19 at 7:45 the rash is still covering her upper torso, face, and both arms. She will finish her Prednisone on 4/13/19 and PEPCID on 4/13/19.
Pt recvd 1 dose of Engerix-B & 18JUN92 exp difficulty in concentrating for approx 24 hrs- 18JUN-19JUN92
Approximately 15 minutes after the shot was given, the patient began shaking, stated he felt faint, then was unresponsive for approximately 30 seconds.  He was pale and diaphoretic.  His blood pressure and respirations remained stable.  He became bradycardic (HR=47-50 BPM).  He was also noted to have a rash on the arm where he received the shot.  Patient received 12.5 mg IV Benadryl, and 125 mg IV solu-medrol and symptoms resolved.
5 DAYS AFTER VACCINE NOTED SWELLING AND REDNESS WITH PAIN IN ARM AT INJECTION SITE.
Headache, NauseaVomiting, facial flushing Narrative: facial flushing; observed for 45 minutes; reports headache and nausea, has hx of migraines-resolved wihin on week